You have 9 free searches left this month | for more free features.

Condition

Advanced Solid Tumor (1)

Solid Tumors (1)

Overall Status

Active, not recruiting (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Harbour BioMed (Guangzhou) Co. Ltd. (1)

Harbour BioMed US, Inc. (1)

Collaborator

Intervention

hbm4003 (2)

toripalimab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

hbm4003

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Solid Tumors Trial (HBM4003, Toripalimab)

Not yet recruiting

Solid Tumors

HBM4003
Toripalimab

(no location specified)

Jan 12, 2022

Advanced Solid Tumor Trial in Australia, China, Hong Kong (HBM4003)

Active, not recruiting

Advanced Solid Tumor

HBM4003

Kogarah, New South Wales, Australia
+16 more

Aug 2, 2022